Compounded GLP-1 Formulation / B12
Compounded GLP-1 receptor agonist with Cyanocobalamin
- Format
- Injectable
- Spec
- Multiple concentrations
- Sourcing
- FDA-registered 503A pharmacy
Research Summary
Mechanism & Physiological Role
GLP-1 receptor agonists activate incretin signaling to promote glucose-dependent insulin secretion, delay gastric emptying, and reduce appetite via central pathways.
Clinical & Research Applications
Discussed in the peer-reviewed literature in the context of weight management and metabolic-syndrome research. 503A compounded formulations are prepared per individual patient prescriptions.
Scientific Publications
Peer-Reviewed References
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding JPH, Batterham RL, Calanna S, et al.
New England Journal of Medicine · 2021 · PMID: 33567185
All compounded formulations are prepared by a licensed 503A sterile compounding pharmacy partner. Compounds are available to NPI-verified licensed practitioners only, per individual patient prescriptions in accordance with applicable state and federal law. Compounded medications are not FDA-approved. Pricing available upon verified account approval.
Ready to add Compounded GLP-1 Formulation / B12 to your protocol?
Compounded formulations are dispensed by our licensed 503A pharmacy partner OBPRx under a valid patient-specific prescription. Prefer a formal quote? Request formulation-specific pricing instead.